Treatments include: * bone marrow transplant * ADA enzyme in PEG vehicle Gene therapy In September 1990, the first gene therapy to combat this disease was performed by Dr. William French Anderson on a four-year-old girl, Ashanti DeSilva, at the National Institutes of Health, Bethesda, Maryland, U.S.A. In April 2016 the Committee for Medicinal Products for Human Use of the European Medicines Agency endorsed and recommended for approval a stem cell gene therapy called Strimvelis, for children with ADA-SCID for whom no matching bone marrow donor is available.
Adenosine deaminase deficiency
Adenosine deaminase 2 deficiency
Adenine phosphoribosyltransferase deficiency
Guanidinoacetate methyltransferase deficiency
Galactose-1-phosphate uridylyltransferase deficiency
Methylenetetrahydrofolate reductase deficiency
Mevalonate kinase deficiency
Adenosine monophosphate deaminase deficiency type 1